EUVIMED · CrossrefZeitschrift
International Journal of Clinical Oncology
ISSN 1341-9625 · Springer Science and Business Media LLC
Neueste Artikel
Risk factors for pneumonitis development in patients with platinum-refractory head and neck cancer treated with salvage-line chemotherapy after nivolumab failure
Practical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours
Self-reported eating speed and the risk of breast cancer among Japanese women: a retrospective cohort study from the LIFE Study
Prognostic impact of surgical resection after chemotherapy in oligometastatic versus non-oligometastatic gastric cancer
Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study
Pharmacotherapy for older adults with cancer: a digest of the Japanese clinical practice guidelines (2nd edition) — lung cancer
Interstitial lung disease in patients with recurrent and metastatic head and neck cancer treated with immune checkpoint inhibitors and cetuximab and/or paclitaxel
Current development and challenges of NK cell-based immunotherapy for gastrointestinal cancers
Circulating tumor DNA methylation and gut microbiota in colorectal cancer: diagnostic, prognostic, and therapeutic implications
Regimen-stratified prognostic associations do not support treatment selection in metastatic renal cell carcinoma
Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis
Reference frequencies of selected non-ICI genomic alterations detected through routine comprehensive genomic profiling in Japan: a nationwide C-CAT study
Reply to Qiyi Lin: Regimen-stratified prognostic associations and treatment-by-host-factor interactions in metastatic renal cell carcinoma
List of reviewers 2025–2026
Correction: Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis
Differential detection of actionable alterations across CGP panels in biliary tract cancer: implications for panel selection
Local ablative therapy plus systemic treatment versus systemic therapy alone in oligometastatic non–small cell lung cancer: a systematic review and meta-analysis of randomized trials
Sex differences in the prognostic value of body mass index after curative nephrectomy for high-risk renal cell carcinoma: a multicenter cohort study
Pharmacotherapy for older adults with cancer: a digest of the Japanese clinical practice guidelines (2nd edition)—general principles
Changes in plasma cfDNA ERBB2 copy number reflect prognosis in HER2-positive gastric cancer: a correlative analysis of the KSCC-TROX A2 study
Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study
Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview
The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study
Impact of prior PARP inhibitor exposure on the efficacy of platinum-based chemotherapy in platinum-sensitive recurrent ovarian cancer: a propensity score-matched analysis
Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis
Artificial intelligence for diagnosis and triage in oral cancer: a clinician‑centered narrative review
Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004–2018)
Intratumoral heterogeneity and chemotherapy-induced alteration of CLDN18.2 expression in resectable gastric cancer
Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma
Long-term intelligence after high-dose radiotherapy to the primary site versus chemotherapy and whole-ventricle radiotherapy in patients with germinoma
EUVIMED